Guide
Mexico COFEPRIS Supplements Readiness: Suplementos Alimenticios Notification, RCSPS Ingredient Limits and NOM-051 Labelling
Mexico regulates dietary supplements as suplementos alimenticios under the Reglamento de Control Sanitario de Productos y Servicios (RCSPS, the Health Control Regulation for Products and Services), administered by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). The category is notification-based — no pre-market authorisation — but the ingredient universe, dose limits, claim controls and Spanish-language labelling under NOM-051-SCFI/SSA1-2010 are tightly defined. Crossing the supplement boundary into therapeutic claims reclassifies the product as a medicamento herbolario or fármaco, which triggers full COFEPRIS registration. This guide maps the COFEPRIS suplemento path for international brands entering Mexico, the third-largest Latin American supplement market.
Start free trial Free trial, no credit card, onboard in days, not months.
Suplemento alimenticio — the legal category and its boundary
Article 215 of the General Health Law (Ley General de Salud) and Article 168 of the RCSPS define suplementos alimenticios as products formulated from plants, foods, nutrients, fermentation derivatives, or combinations thereof, presented in pharmaceutical-like dosage forms (capsule, tablet, sachet, liquid dose, gummy) and intended to increase total dietary intake, complement the diet or supply specific dietary components. The boundary is sharp: a supplement may make structure/function statements (e.g. 'contributes to normal immune function') but cannot make therapeutic, curative, preventive or diagnostic claims, and cannot contain pharmaceutical-grade actives at pharmacological doses. Crossing the line reclassifies the product as a medicamento herbolario (herbal medicine) under Article 224, requiring full COFEPRIS pre-market registration with toxicology, efficacy and stability dossiers — an entirely different regulatory tier.
Notification under RCSPS Article 25 — and what COFEPRIS expects in the file
Supplements are notified to COFEPRIS through the Aviso de Funcionamiento (operational notice) for the importer and the Aviso de Inicio de Comercialización for the product. Notification is not pre-approval — the product can be marketed once the aviso is filed, and COFEPRIS controls compliance through post-market inspection and import-port verification. The file the importer must hold (and produce on COFEPRIS inspection) covers: formulation with per-ingredient quantitative composition, manufacturing process, finished-product specifications, stability supporting the labelled shelf life, GMP evidence from the manufacturing site (foreign GMP — US FDA cGMP, EU GMP, PIC/S, or Mexican NOM-251 — is generally accepted), the Spanish label artwork, the safety basis for any non-traditional ingredient, and the importer's Aviso de Funcionamiento.
Ingredient limits — RCSPS, NOMs and the COFEPRIS prohibited list
The ingredient universe sits across several instruments: RCSPS Annexes for general food ingredients, NOM-218-SSA1 (non-alcoholic beverages including some supplement formats), NOM-247-SSA1 (cereals and seeds), and the COFEPRIS-published prohibited and restricted ingredient list (regularly updated, covering pharmaceutical-grade actives like sibutramine, sildenafil analogues, anabolic steroids, ephedra, kava at non-traditional doses, and a long roster of adulterants COFEPRIS has caught in seized products). Vitamin and mineral doses are constrained by the Recommended Daily Intake values published by the Federal Commission. Botanical ingredients must have a recognised monograph (Farmacopea Herbolaria de los Estados Unidos Mexicanos — FHEUM — is the domestic reference) or accepted international monograph (USP, EP, WHO).
Spanish labelling — NOM-051, the GDA front-of-pack and the mandatory disclaimers
Mexican supplement labels are governed by NOM-051-SCFI/SSA1-2010 (general labelling for pre-packaged foods and non-alcoholic beverages) and its 2020 modification introducing the octagonal black warning stamps (Sellos) for high-fat/sodium/sugar/calorie content. Mandatory in Spanish: product name with the category 'Suplemento Alimenticio', list of ingredients, net content in legal metric units, nutritional declaration table per serving and per 100 g/ml, allergen statement, manufacturer/importer/distributor with RFC, country of origin, batch number and expiry, storage instructions, the COFEPRIS aviso reference, the dose and the suggested-use statement. Mandatory disclaimers: 'El consumo de este producto es responsabilidad de quien lo recomienda y de quien lo usa' ('Consumption of this product is the responsibility of those who recommend and use it') and 'No es un medicamento' ('It is not a medicine'). The octagonal Sellos warnings apply where thresholds are exceeded.
A 120-day Mexico entry path
Days 1–15: category gate (suplemento vs medicamento herbolario), prohibited-list and RDI dose-limit check, claim scrub against the structure/function boundary. Days 16-35: importer setup — RFC, Aviso de Funcionamiento for the warehouse, Padrón de Importadores enrolment with SAT. Days 36-60: Spanish label build under NOM-051 with Sellos analysis, mandatory disclaimers, nutritional table. Days 61-80: Aviso de Inicio de Comercialización per product, COFEPRIS technical clarifications. Days 81-100: first shipment under the aviso, customs clearance with COFEPRIS port verification, GMP evidence retention for inspection. Days 101-120: distributor onboarding, adverse-event reporting setup (vigilance routed through the Aviso de Funcionamiento holder).
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Modules that do the work
COFEPRIS aviso and importer records
Aviso de Funcionamiento, Aviso de Inicio on one SKU spine.
Prohibited-list and dose-limit gate at spec stage
Non-permitted ingredient or over-dose caught before aviso filing.
COFEPRIS port verification and vigilance
Customs holds and AE reports compiled, not scattered.
Industries this hits hardest
Frequently asked
Do I need COFEPRIS pre-approval to sell a supplement in Mexico?
No. Suplementos alimenticios are notified (Aviso de Inicio de Comercialización), not pre-approved. The product can be marketed once the aviso is filed, with the importer holding the technical file for post-market inspection. Medicamentos herbolarios are different — those require full COFEPRIS registration with toxicology, efficacy and stability.
What turns a supplement into a medicine under COFEPRIS?
Therapeutic, curative, preventive or diagnostic claims; pharmaceutical-grade actives at pharmacological doses; ingredients on the COFEPRIS restricted/prohibited list at non-traditional doses; or formulation outside the RCSPS Article 168 supplement definition. Any of these reclassifies the product as a medicamento herbolario (Article 224) and triggers full registration.
Can I use a US Supplement Facts panel as my Mexican label?
No. Mexico requires its own nutritional declaration table under NOM-051 (per serving and per 100 g/ml), the octagonal Sellos warning stamps for high-fat/sodium/sugar/calorie products, Spanish-language ingredient list, mandatory 'No es un medicamento' disclaimer, and the importer's regulatory references. The US panel does not satisfy NOM-051.
Is foreign GMP accepted for COFEPRIS notification?
Generally yes — US FDA cGMP (21 CFR 111 for supplements), EU GMP, PIC/S inspectorate certificates and the Mexican NOM-251-SSA1 are all accepted GMP evidence for the supplement manufacturing site. The evidence must be current and cover the supplement dosage form. COFEPRIS retains the right to require additional inspection for higher-risk formats.
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
Related reading
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
Spot something off? .